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Fetal outcomes after uteroplacental insufficiency (UPI) include growth restriction 
and sex-divergent increase in neonatal and adult-onset disease. Fetal acquisition of long-
chain polyunsaturated fatty acids (LCPUFA) is 1) linked to disease outcomes, 2) 
mediated by the placenta, and 3) impaired in pregnancies complicated by UPI. 
Peroxisome proliferator activated receptor gamma (PPARγ) regulates placental LCPUFA 
transport via direct control of gene expression and by initiating chromatin modifications 
through Setd8. We previously showed in our rat model that UPI results in fetal growth 
restriction and development of sex-divergent neonatal and adult-onset disease. We 
hypothesize that UPI in the rat results in sex-divergent changes in the placental PPARγ-
Setd8 axis and sex-divergent changes in fetal serum LCPUFA profiles.  
UPI was induced by bilateral uterine artery ligation at embryonic day 19 in 
pregnant Sprague Dawley rats. Male and female fetal rat serum and corresponding 
placenta were surgically collected at term (embryonic day 21). Serum LCPUFA profiles 
were measured using gas chromatography-mass spectrometry. mRNA was measured 
using real-time RT-PCR, protein was measured using western blotting, and PPARγ 
occupancy at the Setd8 promoter was measured using ChIP.  
Data are expressed as mean  standard deviation (SD), *p<0.05. UPI did not 
affect PPARγ mRNA levels and protein abundance in male placenta or female placenta 
compared to sex-matched control. UPI increased Setd8 mRNA levels, protein abundance, 
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and total PPARγ at the promoter of the Setd8 compared to sex-matched control in male 
placenta but not in female placenta. In male placenta, UPI increased global H4K20me 
compared to sex-matched control. No differences were observed in female placenta. In 
male fetuses, UPI increased the LCPUFA palmitic acid (PAL), linoleic acid (LA), and 
arachidonic acid (AA), while decreasing palmitoleic acid (PA), eicosapentaenoic acid 
(EPA), and docosahexaenoic acid (DHA). In female fetuses, UPI increased AA with no 
change in other LCPUFA. 
 In conclusion, UPI in the rat results in sex-divergent changes in the PPARγ-Setd8 
axis in association with sex-divergent changes in fetal serum LCPUFA profiles. Given 
the role of Setd8 in chromatin maintenance, sex-divergent changes in PPARγ-driven 
Setd8 expression may influence UPI-induced sex-divergent changes in the placental 
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Developmental Origins of Health and Disease 
The developmental origins of health and disease (DOHaD) were first described by 
Barker et al., with the recognition that perinatal events were important determinants of 
health later in life.1 DOHaD begins in utero. Adverse prenatal events, including maternal 
diet, obesity, toxin exposure, and pathologic conditions of pregnancy, lead to sex-
divergent organ-specific structural and functional changes that contribute to disease onset 
in the neonate and adult periods. Such insults can establish heritable patterns of 
epigenetic marks, such as chromatin modifications, that “program” states of gene 
expression in offspring.2  
One pathological condition of pregnancy is uteroplacental insufficiency (UPI). In 
developed countries, a major cause of UPI is preeclampsia. UPI is characterized by 
impaired placental blood flow to the fetus, resulting in compromised transport of oxygen 
and nutrients to the fetus. Organ-specific structural and functional changes resulting from 
UPI may allow the fetus to survive in utero but may predispose the offspring to disease 
onset in the long run.3,4 Disease outcomes involve many organ systems and include 
metabolic diseases such as type 2 diabetes, cardiovascular disease, obesity, and impaired 
neurodevelopment. An important caveat is that disease outcomes are sex-divergent with 
males often having worse outcomes than females.  
The placenta is the key interface between the maternal environment and the 
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developing fetus and is appreciated to contribute to developmentally programmed sex-
divergent disease outcomes.5 The placenta is genetically aligned with the sex of the fetus 
and responds to stressors (like UPI) in a sex-divergent manner. Male and female placenta 
display unique UPI-induced changes in placental structure, efficiency, and molecular 
characteristics. Differences in structure, function, and adaptation between male and 
female placenta are now being appreciated.3  
 
Long-Chain Polyunsaturated Fatty Acids 
In pregnancies complicated by UPI, the placenta impairs transport of oxygen and 
nutrients to the fetus. This impairment is especially the case for long-chain 
polyunsaturated fatty acids (LCPUFA) which are selectively transferred to the fetus 
during late gestation. The placenta regulates selective transport of LCPUFA from 
maternal to fetal circulation and also storage of LCPUFA in the placenta for membrane 
construction and energy production.6,7  
Fetal acquisition of LCPUFA is critical for normal development. Specifically, 
impaired fetal LCPUFA acquisition during development is associated with neonatal and 
adult disease.8,9 Impaired fetal LCPUFA acquisition occurs in pregnancies complicated 
by UPI. Little is known about the mechanisms regulating LCPUFA metabolism in the 
placenta in normal pregnancies and pregnancies complicated by UPI. Furthermore, the 
current literature rarely considers the sex of the placenta as a variable even though 





PPARγ and Setd8 
Peroxisome proliferator activated receptor gamma (PPARγ) is a transcription 
factor activated by LCPUFA and their metabolites. PPARγ is a key regulator of signaling 
pathways governing LCPUFA metabolism in the placenta. In many tissues, including 
placenta, PPARγ regulates LCPUFA metabolism by directly promoting the transcription 
of lipid metabolizing genes. In nonplacental tissue, PPARγ regulates LCPUFA 
metabolism by indirectly influencing the transcription of suites of fatty acid metabolizing 
genes via chromatin modifications. However, whether indirect regulation of LCPUFA 
metabolism occurs in the placenta via PPARγ and its downstream target gene Setd8 
(Figure 1) is unknown. The aim of this study is to investigate the sex-divergent effects of 
UPI on the placental PPARγ-Setd8 axis and quantify LCPUFA profiles of offspring in 
the rat.  
 
Hypothesis  
DOHaD begins in utero. UPI results in structural and functional changes that 
leads to impaired fetal acquisition of LCPUFA and sex-divergent programming of 
metabolic disease. Placental LCPUFA metabolism is governed by PPARγ, and in non-
placental tissue, PPARγ targets the epigenetic modifier Setd8.  
We hypothesized that UPI induces sex-divergent changes in the PPARγ-Setd8 
axis in rat placenta. We further hypothesized that this occurs in association with sex-








Figure 1. The PPARγ-Setd8 axis. A) Ligand activated PPARγ protein, a transcription 
factor, binds to a PPAR response element (PPRE) in the promoter of the Setd8 gene. The 
Setd8 gene is transcribed and translated to the Setd8 protein. B) The Setd8 protein, a 
histone lysine methyltransferase, enzymatically places a monomethyl group on Histone 4 
Lysine 20 on suites of various LCPUFA metabolizing target genes. The presence of the 







Rat Model of UPI 
UPI was induced in pregnant, Sprague-Dawley rat dams by bilateral uterine artery 
ligation on embryonic day 19 (E19) as previously described.10,11 Control rat dams 
underwent comparable anesthesia but did not undergo surgery.  At embryonic day 19 
(E19), rat pups were delivered by C-section and separated into male or female groups. At 
embryonic day 21 (E21), rat offspring underwent euthanasia, and placenta and serum 
from male and female rat pups was collected and immediately flash frozen in liquid 
nitrogen. Samples were stored at -80C. In this study, we examined 4 groups: male 
control, male UPI, female control, and female UPI. Each group consisted of n=8 rat pups 
derived from different litters. Our lab has previously demonstrated in our rat model that 
UPI results in offspring that are asymmetrically growth restricted, have sex-divergent 
programming of adult metabolic disease onset in various tissues (adipose, lung, liver, and 




Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to 
measure mRNA transcript levels of PPARγ and Setd8 in whole placenta homogenate of 
control and UPI rat pups. RNA was extracted from placenta tissue samples using an 
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RNeasy Mini Kit (Qiagen). cDNA was generated using a High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). The following Assay-on-Demand primer/probe 
sets were used: PPAR Rn01492274_m1; Setd8 Rn01477383_g1; GAPDH-
Mm99999915_g1. GAPDH was used as an internal control. GAPDH primer and probe 
sequences were as follows: Forward: CAAGATGGTGAAGGTCGGTGT; Reverse: 
CAAGAGAAGGCAGCCCTGGT; Probe: GCGTCCGATACGGCCAAATCCG. Data 
and RT-PCR amplification were analyzed by the QuantiStudio 12K Flex Real Time PCR 
system at the University of Utah Core Facility. 
 
Western Blot 
Western blotting was used to measure protein abundance of PPAR, Setd8, and 
global acid extracted H4K20me in whole placenta homogenate of control and UPI rat 
pups. Rat placenta tissue was crushed using a mortar and pestle with liquid nitrogen. 
Total protein was isolated from rat pup whole placenta homogenate using RIPA buffer 
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.5% Na-deoxy-cholate, 1% NP- 40 (Igepal), 
and 0.1% SDS) and protease inhibitor cocktail (Roche-Complete Mini). Pierce BCA 
protein assay kit (ThermoScientific) was used to quantify protein abundance. Protein 
samples were stored at -80C until use. A total of 30 μg of protein homogenate was 
loaded on Bis-Tris Gels (Novex by Life Technologies) to analyze protein abundance. 
GAPDH was used as an internal control for all experiments. The following antibodies 
were used: PPAR sc-271392 (Santa Cruz Biotechnology); Setd8 ab177488 (abcam); 
H4k20me ab9051 (abcam); H4 2592 (Cell Signaling Technology); GAPDH 14C10 (Cell 
Signaling Technology). Antibodies were detected with Western Lightning enhanced 
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chemiluminescence and quantified using an Image Station 2000R (Eastman Kodak). 
 
Chromatin Immunoprecipitation 
Chromatin immunoprecipitation (ChIP) was used to measure PPAR occupancy 
at the promoter regions of the Setd8 output gene. Rat placenta tissue was crushed using a 
mortar and pestle with liquid nitrogen. Crosslinking and chromatin isolation was 
performed as previously described in rat pup whole placenta homogenate.10,11 ChIP was 
conducted using the EpiQuik Chromatin Immunoprecipitation (ChIP) Kit (Epigentek 
Group Inc.) according to manufacturer’s directions. We used antibody PPAR ab41928 
(abcam). The following primer and probe sequences were used: (Setd8 primer and probe 
sequences: Forward: AGCCCAGCCCTTCGAATC; Reverse: 
CAGCAGGGAGGTCAGAATGAC; Probe: AGAGTCAGTTTTCCC. Samples were 
transferred to the University of Utah Core Facility where qPCR was used to quantify 
PPAR occupancy at the Setd8 promoter.  
 
Serum Fatty Acids 
Serum fatty acid profiles were quantified using gas chromatography-mass 
spectrometry (GC-MS) at the University of Utah Core Facility. Frozen serum was 
transferred to the University of Utah Core Facility to quantify relative amounts of fatty 







UPI rat pups were compared to sex-matched control pups. Male and female rats 
were considered separate groups. Data are expressed as mean  standard deviation (SD) 
for a sample size of n=8 per group. Mann Whitney U test was used to detect statistically 
significant differences between UPI groups and sex-matched controls. Two-way ANOVA 
was used to determine significant interaction effects between UPI and sex. Statistical 









 First, we measured PPAR mRNA transcript levels and protein abundance 
relative to GAPDH in rat placenta tissue. We detected no basal sex differences in PPAR 
mRNA transcript levels between male control and female control. UPI did not alter levels 
of PPAR mRNA transcript levels compared to sex-matched control in male or female 
placenta (Figure 2). Similarly, we detected no basal sex differences in PPAR protein 
abundance between male control and female control. UPI did not alter levels of PPAR 
protein abundance compared to sex-matched control in male or female placenta (Figure 
3).   
 
Setd8 
In order to assess downstream PPAR signaling, we measured Setd8 mRNA 
transcript levels and protein abundance relative to GAPDH rat placenta tissue. We 
detected no basal sex differences in Setd8 mRNA transcript levels between male control 
and female control. UPI significantly increased Setd8 mRNA transcript levels compared 
to sex-matched control in male placenta (p<0.05) but not female placenta (Figure 4). A 
significant interaction effect between UPI and sex was observed for Setd8 mRNA 
(p<0.05). We detected no basal sex differences in Setd8 protein abundance between male 
control and female control. Similarly, UPI increased Setd8 protein abundance compared 
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to sex-matched control in male (p<0.05) but not female placenta (Figure 5). Again, a 
significant interaction effect was observed between UPI and sex for Setd8 protein 
(p<0.05). We also measured PPAR occupancy at the Setd8 promoter region expressed as 
% input. Compared to sex-matched control, UPI increased PPAR occupancy at the 
Setd8 promoter in male placenta (p<0.05) but did not affect occupancy in female placenta 
(Figure 6).   
 
H4K20me 
To assess the activity of Setd8, we quantified global H4K20me relative to total 
H4 protein. Global H4K20me was significantly increased in control male placenta 
compared to control female placenta (p<0.05). Furthermore, UPI increased global 
H4K20me in male placenta compared to sex-matched control (p<0.05), but no 
differences were observed between female placenta and sex-matched control (Figure 7).  
 
Serum Fatty Acids 
Finally, in order to understand the effects of UPI on serum fatty acid profiles, we 
measured saturated fatty acids, monounsaturated fatty acids, omega-6 fatty acids, and 
omega-3 fatty acids in rat pup serum. Fatty acid profiles were compared to weight% of 
total fatty acids. We detected no basal sex differences in fatty acids between male control 
and female control.  UPI increased palmitic acid (PAL), linoleic acid (LA), and 
arachidonic acid (AA) and decreased palmitoleic acid (PA), eicosapentaenoic acid (EPA), 
and docosahexaenoic acid (DHA) compared to sex-match control (p<0.05). UPI 
increased AA only in female placenta compared to sex-matched control (p<0.05). We 
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observed a significant interaction effect between UPI and sex for PAL, PA, and EPA in 
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Figure 2. PPAR mRNA transcript levels relative to GADPH (n=8/group). *p<0.05 
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Figure 3. PPAR protein abundance relative to GAPDH (n=8/group). *p<0.05 compared 
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Figure 4. Setd8 mRNA transcript levels relative to GAPDH (n=8/group). *p<0.05 
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Figure 5. Setd8 protein abundance relative to GAPDH (n=8/group). *p<0.05 compared to 
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Figure 6. PPAR occupancy at the Setd8 promoter expressed as % input (n=8/group). 
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Table 1. Serum Fatty Acids in Male and Female Term Rat Fetuses 
 Male Female 
Fatty Acid 
(wt:wt% of FA) 
Control UPI Control UPI 
Palmitic (16:0) 21.6 ± 1.2 23.7 ± 1.1* 21.4 ± 1.1 20.6 ± 1.7† 
Stearic (18:0) 9.7 ± 0.5 10.5 ± 1.0 9.4 ± 0.7 10.0 ± 2.2 
Palmitoleic (16:1) 4.6 ± 0.7 2.3 ± 1.0* 4.8 ± 0.6 4.0 ± 07† 
Oleic (18:1) 18.8 ± 1.8 19.7 ± 3.7 18.7 ± 2.6 18.3 ± 4.0 
Linoleic (18:2, ω-6) 9.9 ± 0.5 12.6 ± 1.7* 9.4 ± 1.3 10.6 ± 0.9 
Arachidonic (20:4, ω-6) 7.9 ± 0.2 11.8 ± 1.9* 7.0 ± 0.9 9.0 ± 1.2* 
Α-Linolenic (18:3, ω-3) 2.2 ± 0.4 2.7 ± 0.4 2.2 ± 0.7 2.1 ± 0.2 
Eicosapentaenoic (20:5, ω-3) 3.0 ± 0.4 0.8 ± 0.4* 2.9 ± 1.2 2.6 ± 1.0† 
Docosahexaenoic (22:6, ω-3) 3.9 ± 0.6 2.9 ± 0.5* 3.4 ± 1.2 3.6 ± 0.7 
 








The purpose of this study was to investigate the sex-divergent effects of UPI on 
the placental PPARγ-Setd8 axis and quantify serum LCPUFA profiles of offspring in the 
rat. We demonstrated that UPI causes sex-divergent changes in placental PPARγ-Setd8 
signaling in association with altered serum LCPUFA profiles. These data emphasize the 
importance of sex of the placenta and how it may impact LCPUFA metabolism and 
molecular signaling in UPI pregnancies. Knowledge gained from this research adds to the 
understanding of mechanisms involved in placental LCPUFA metabolism. These data 
will inform studies aimed at determining the mechanisms by which the placenta 
contributes to the developmental programming of disease.    
Our research is consistent with previous work conducted in adipose tissue. 
Wakabayashi et al. demonstrated the presence of the PPARγ-Setd8 axis in adipose tissue 
and that PPARγ upregulates the expression of Setd8.12 To our knowledge, our study is the 
first to report the PPARγ-Setd8 axis in placenta tissue. PPARγ mRNA levels and protein 
abundance were not different between groups. However, Setd8 mRNA levels, Setd8 
protein abundance, and PPARγ binding at the Setd8 promoter were increased in male 
placenta compared to sex-matched control, demonstrating that PPARγ upregulates the 
expression of Setd8. We also demonstrated a significant interaction effect between UPI 
and sex for Setd8 mRNA levels and protein abundance. This significant interaction effect 
suggests that changes in Setd8 expression are sex-divergent. 
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Studies clearly show that the placental transcriptome and DNA methylation 
profile is different between male and female placenta.13-15 It has been suggested that 
female placenta develop slowly, investing more nutrients into the placenta itself which 
allows females to adapt to insults late in gestation. Conversely, male placentas may 
develop more quickly and earlier in gestation. Quick development allows more nutrients 
to be invested into the fetus itself but may result in males being unable to adapt to late 
gestation insults.3 Our results showed that LCPUFA profiles of offspring are altered in a 
sex-divergent manner in UPI pregnancies. In males, UPI increased PAL, LA, AA and 
decreased PA, EPA, and DHA. In females, UPI increased AA. A significant interaction 
effect between UPI and sex was observed in female placenta for PAL, PA, and EPA. 
These data suggest that female placenta may be able to adapt to a late gestational insult to 
restore LCPUFA profiles to normal levels. We speculate that a late gestational insult may 
result in compensatory molecular signaling to increase transcription of specific target 
genes in male placenta.  
Our study has strengths and limitations. The UPI rat model is a strength of the 
study because it is well-characterized. Furthermore, since UPI is induced late in gestation 
and rat pups are delivered two days after surgery, physiological maternal adaptations are 
excluded. Bilateral uterine artery ligation compromises blood, oxygen, and nutrient 
transfer from maternal circulation to the fetus. Thus, observed changes in placental 
PPAR signaling and LCPUFA metabolism are likely due to feedback from the fetus. 
Another strength of the study is that we investigate molecular changes with phenotypic 
outcomes. Our study examines molecular measures of PPAR and its downstream targets 
in addition to phenotypic serum LCPUFA in term rat fetuses.  
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A limitation to the study is that molecular measurements were done in whole 
placenta homogenate and, therefore, were from multiple cell types of the placenta.  
Ongoing studies are mastering techniques to isolate specific cell types in the placenta. 
While our study is investigating PPAR, we recognize that we have not considered all 
molecules involved in placental LCPUFA metabolism. We also recognize compensatory 
PPARγ signaling may have occurred following UPI. Our study is descriptive, and we will 
not establish a cause and effect relationship between PPAR signaling and LCPUFA 
metabolism. Ongoing studies in the lab are supplementing rat dams with diets containing 
DHA in the context of UPI to determine if serum lipid profiles can be restored in term rat 
fetuses. Lastly, our study did not examine specific target genes affected by increased 
H4K20me. Ongoing studies are investigating specific targets of Setd8 and the effect of 
increased H4K20me along the length of the genome. We speculate that the H4K20me 
increases transcription of fatty acid transport protein (FATP) and fatty acid binding 
protein (FABP) genes. Specifically, we speculate FATP2 may be a target of the PPAR-
Setd8 axis since PPARγ is a regulator of FATP2. Additionally, Lager et al. demonstrated 
that FATP2 is upregulated in placenta tissue in overweight/obese pregnancies and 
speculated that increased FATP2 expression could contribute to increased LCPUFA 
transfer to the fetus.16 
Future studies should aim to examine the sex-divergent effects of UPI on the 
PPAR-Setd8 axis in specific cell types and layers in the placenta. Human and animal 
studies have examined the mRNA and less often the protein levels of PPARγ in the 
placenta of normal and pathologic pregnancies. In preeclampsia, human and animal 
studies show altered placental PPARγ mRNA in association with disturbed placental lipid 
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metabolism and fetal outcomes.17-20 Furthermore, many studies yield conflicting results 
in the effects of therapeutic maternal LCPUFA supplementation during pregnancy. Some 
studies suggest a positive effect while other studies are inconclusive or yield negative 
results.21-29 We speculate a sex-based mechanism by which placental LCPUFA handling 
is altered in UPI pregnancies and, therefore, future studies should investigate how the 
placenta responds to sex-specific therapeutic supplementation of LCPUFA in the context 
of UPI pregnancies.  Since the placental transcriptome and methylation patterns are 
different between male and female placenta, future studies should consider sex as a 
variable.  
In conclusion, in male rat placenta, UPI alters the placental PPARγ-Setd8 axis in 
a sex-divergent manner. UPI increased Setd8 mRNA, protein levels of Setd8, PPAR 
occupancy at the Setd8 promoter, and global H4K20me in male rat placenta. These 
changes occurred in association with sex-divergent changes in LCPUFA profiles in term 
gestation male rat pups. In female rats, UPI does not affect the placental PPARγ-Setd8 
axis. We speculate our results represent a sex-based mechanism by which placental 
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